INTENCIVE Project, in which IDIVAL participates together with 5 European regions, continues working on its objective of improving the implementation of policies and programmes in terms of health technology innovation-driven and customer-oriented health services in the partner regions. Meetings and visits are regularly held with European partners in order to obtain an overview of the […]
Individuals with alterations in magnesium levels have an increased risk of presenting fatty liver disease with inflammation and fibrosis, as concluded by a study that has just been published in Journal of Hepatology. Non-alcoholic steatohepatitis, characterized by inflammation and liver fibrosis, is associated with obesity and has a worldwide prevalence of 1.7 billion people. Unhealthy […]
Cohorte Cantabria will allow to know in depth the characteristics of the population of Cantabria and its behavior in key aspects for health such as lifestyle habits, risk factors for getting sick, the causes of the main diseases and, even more importantly, favoring development of personalized, predictive and preventive medicine. These are the main objectives […]
The PsicAP project is the largest mental health care clinical trial ever conducted in Spain to date, about the efficacy of psychological treatment for people with emotional disorders in Primary Care (PC). The study has just published its results in the journal Psychological Medicine. The results confirm that adding a group psychological treatment of 7 […]
The crisis generated by the pandemic derived from COVID-19 in extreme contingency scenarios presents a terrible dilemma: first, it is to protect the health of citizens, although that can hibernate the economy and cause a reduction in income with unequal effects by socioeconomic gradient and by Regional Health Service. In this sense, the Transversal Group […]
Recently, a multicenter retrospective has been published in the American Journal of Transplantation in which six of the seven hospitals that perform lung transplantation in Spain have participated and which are the following: Vall d'Hebron (Barcelona), La Fe (Valencia) , Marqués de Valdecilla (Santander), Reina Sofía (Córdoba), Puerta de Hierro (Madrid), October 12 (Madrid), and […]
The Marqués de Valdecilla University Hospital Rheumatology Unit, in collaboration with the Valdecilla Health Research Institute (IDIVAL), has launched a study to determine the relationship between immunological inflammatory diseases and SARS-CoV-2. Developed by doctors Ricardo Blanco, Miguel Ángel González-Gay and David Martínez-López, the objectives of this research in patients with rheumatological diseases with an immune […]
The Marqués de Valdecilla University Hospital has been one of the 3 Spanish hospitals selected to participate in an international study investigating a vaccine, Ad26COVS, against the SARS-CoV-2 coronavirus, which is responsible for the COVID-19 disease. Thanks to the collaboration of healthy volunteers, the aim is to evaluate the immune response to different doses of […]
The ISCIII through the extraordinary call for research projects on SARS-COV-2 and the Covid-19 disease has financed the project “Seroprevalence against SARS-CoV-2 in pregnant women and newborns” directed by Dr. Cabero -Head of the Pediatrics Service- and Dr. Llorca -Professor of Preventive Medicine and Public Health-. This project aims to know the impact that COVID-19 […]
The multidisciplinary work team formed by the group of Cell Signaling and Therapeutic Targets in Cancer of IDIVAL; the Optics group of the University of Cantabria (UC) and the Neurosurgery service of the Marqués de Valdecilla University Hospital (HUMV); Together with the company Fotoglass, specialized in biomedical optics, a spin off of UC, they have […]
